null

SMILES: CC(=O)Nc1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(cc4CC3)C#N)CC2)c1F

InChI Key: InChIKey=HKAVEMLHBNPBSZ-PTTOYHQWSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50218406   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
D(3) dopamine receptor (Homo sapiens (Human))	BDBM50218406 (CHEMBL86183) Show SMILES CC(=O)Nc1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(cc4CC3)C#N)CC2)c1F |wU:14.13,wD:17.17,(30.45,-21.85,;29.68,-20.52,;30.45,-19.19,;28.14,-20.53,;27.35,-19.19,;28.12,-17.86,;27.35,-16.52,;25.81,-16.52,;25.04,-17.86,;23.48,-17.86,;22.71,-16.53,;21.17,-16.52,;20.4,-17.85,;20.42,-15.17,;18.88,-15.17,;18.11,-16.5,;16.55,-16.5,;15.78,-15.17,;14.24,-15.15,;13.49,-13.82,;11.95,-13.8,;11.28,-12.41,;9.78,-12.07,;8.59,-13.03,;7.26,-12.26,;5.91,-13.03,;5.91,-14.57,;7.26,-15.34,;8.59,-14.57,;9.78,-15.52,;11.28,-15.17,;4.56,-15.34,;3.23,-16.11,;16.55,-13.82,;18.11,-13.82,;25.81,-19.19,;25.02,-20.53,)| Show InChI InChI=1S/C30H35FN4O2/c1-21(36)33-28-4-2-3-25(30(28)31)9-12-29(37)34-27-10-6-22(7-11-27)13-16-35-17-14-24-8-5-23(20-32)19-26(24)15-18-35/h2-5,8-9,12,19,22,27H,6-7,10-11,13-18H2,1H3,(H,33,36)(H,34,37)/b12-9+/t22-,27-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity towards human Dopamine receptor D3 by displacement of [125I]iodosulpiride expressed in CHO cells				Bioorg Med Chem Lett 10: 2553-5 (2000) BindingDB Entry DOI: 10.7270/Q24Q7X55
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM50218406 (CHEMBL86183) Show SMILES CC(=O)Nc1cccc(\C=C\C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(cc4CC3)C#N)CC2)c1F |wU:14.13,wD:17.17,(30.45,-21.85,;29.68,-20.52,;30.45,-19.19,;28.14,-20.53,;27.35,-19.19,;28.12,-17.86,;27.35,-16.52,;25.81,-16.52,;25.04,-17.86,;23.48,-17.86,;22.71,-16.53,;21.17,-16.52,;20.4,-17.85,;20.42,-15.17,;18.88,-15.17,;18.11,-16.5,;16.55,-16.5,;15.78,-15.17,;14.24,-15.15,;13.49,-13.82,;11.95,-13.8,;11.28,-12.41,;9.78,-12.07,;8.59,-13.03,;7.26,-12.26,;5.91,-13.03,;5.91,-14.57,;7.26,-15.34,;8.59,-14.57,;9.78,-15.52,;11.28,-15.17,;4.56,-15.34,;3.23,-16.11,;16.55,-13.82,;18.11,-13.82,;25.81,-19.19,;25.02,-20.53,)| Show InChI InChI=1S/C30H35FN4O2/c1-21(36)33-28-4-2-3-25(30(28)31)9-12-29(37)34-27-10-6-22(7-11-27)13-16-35-17-14-24-8-5-23(20-32)19-26(24)15-18-35/h2-5,8-9,12,19,22,27H,6-7,10-11,13-18H2,1H3,(H,33,36)(H,34,37)/b12-9+/t22-,27-	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	501	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SmithKline Beecham Pharmaceuticals Curated by ChEMBL					Assay Description Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells				Bioorg Med Chem Lett 10: 2553-5 (2000) BindingDB Entry DOI: 10.7270/Q24Q7X55
					More data for this Ligand-Target Pair